Camelot Portfolios’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$838K Sell
2,109
-141
-6% -$40.1K 0.59% 56
2026
Q1
$390K Buy
2,250
+34
+2% +$6.97K 0.29% 121
2025
Q4
$568K Sell
2,216
-166
-7% -$43.5K 0.35% 98
2025
Q3
$620K Sell
2,382
-91
-4% -$23.9K 0.37% 90
2025
Q2
$604K Sell
2,473
-650
-21% -$162K 0.36% 91
2025
Q1
$826K Buy
3,123
+860
+38% +$233K 0.51% 68
2024
Q4
$574K Buy
+2,263
New +$607K 0.62% 59
2024
Q3
Sell
-513
Closed -$192K 327
2024
Q2
$192K Buy
+513
New +$173K 0.11% 181

Other funds holding HUM

Camelot Portfolios's HUM Position: Q2 2026 in Review

Camelot Portfolios reduced its Humana (HUM) stake by 6.3% in Q2 2026, selling an estimated $40.1K and leaving 2,109 shares worth $838K. The position accounts for 0.59% of the portfolio, ranked #56.

Camelot Portfolios first reported a position in HUM in Q2 2024 and has held it in 8 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Camelot Portfolios held 2,109 shares of Humana worth $838K as of Q2 2026.
  • Camelot Portfolios sold 141 Humana shares in Q2 2026, an estimated $40.1K.
  • Humana made up 0.59% of Camelot Portfolios's portfolio in Q2 2026, its #56 holding.
  • Camelot Portfolios first reported a position in Humana in Q2 2024 and has held it in 8 quarters since.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Camelot Portfolios's 13F filing for Q2 2026, filed 17 Jul 2026.